Continuous Peripheral Nerve Block Catheter (CPNBC) Market Expected to Witness a Sustainable Growth over 2026

0
10
Continuous Peripheral Nerve Block Catheter (CPNBC) Market

Continuous peripheral nerve block catheter are used to perform a nerve block procedure for pain management. A continuous peripheral nerve block (CPNB) also known as perineural local anaesthetic infusion is a procedure majorly performed in hospitals and ambulatory surgical centres where percutaneous insertion of catheter, adjacent to a peripheral nerve is performed for administration of anaesthesia via the catheter. CPNB analgesia can be continued outside the hospital setting.

The global continuous peripheral nerve block catheter market is estimated to be valued at US$ 698.9 Mn by 2026 end, due to increasing adoption of continuous peripheral nerve block catheter especially in hospitals; as a result of increased precision of catheter placement and lower cost as compared to alternative methods used for administration of analgesia.

Drivers and Trends

Increasing prevalence of chronic diseases, such as osteoarthritis, is leading to the rise in upper/lower extremity joint replacement procedures. CPNB is used for administration of analgesia and post joint replacement procedures for pain management. These factors are expected to fuel revenue growth of the continuous peripheral nerve block catheter market globally over the forecast period. Cost effectiveness offered by continuous peripheral nerve block catheter and reduced hospital stay is further fueling revenue growth of the continuous peripheral nerve block catheter market. Factors such as lack of standard usage guidelines and trained professionals for placement of continuous peripheral nerve block catheter and complications associated with the device are expected to hamper growth of the global continuous peripheral nerve block catheter market. Major trends in the continuous peripheral nerve block catheter market include product modifications and innovations, strategic marketing campaigns and partnerships and acquisitions to increase consumer base.

Analysis, by Region

North America is expected to dominate the global continuous peripheral nerve block catheter market and is projected to register a CAGR of 6.4% in terms of value over the forecast period, with the U.S expected to dominate the North America Continuous Peripheral Nerve Block Catheter market over the forecast period. The North America continuous peripheral nerve block catheter market accounted for 42.3% revenue share of the overall market in 2015. The Japan market is projected to expand at a healthy CAGR of 5.7% during the forecast period. The APEJ market is estimated to account for 10.2% revenue share of the global continuous peripheral nerve block catheter market by the end of 2016.

Analysis, by Product

On the basis of product type, the continuous peripheral nerve block catheter market is segmented into stimulating catheter system, non-stimulating catheter system and over the needle catheter system. In terms of value, the non-stimulating catheter system segment is expected to account for the maximum share of the global continuous peripheral nerve block catheter market over the forecast period. The over the needle catheter system segment is expected to register lower CAGR as compared to other segments over the forecast period, in terms of value. In terms of volume, the non-stimulating catheter system segment is expected to dominate the global continuous peripheral nerve block catheter market throughout the forecast period. The stimulating catheter system product segment accounted for 31.4% revenue share of the overall market in 2015.

Analysis, by Insertion Technique

On the basis of insertion technique, the continuous peripheral nerve block catheter market is segmented into nerve stimulation and ultrasound insertion technique segments. In terms of value, ultrasound segment is expected to register a higher CAGR as compared to nerve stimulation segment by the end of forecast period. Increasing adoption of ultrasound guided catheter systems in the developed regions is expected to further fuel revenue growth of the overall continuous peripheral nerve block catheter market over the forecast period. The revenue share of nerve stimulation segment is expected to decline over the forecast period as nerve stimulation technique offers less precision. Ultrasound segment accounted for 36.8% revenue share of the overall market in 2015.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1307

Analysis, by Indication

On the basis of indication, the continuous peripheral nerve block catheter market is segmented into trauma cases, upper extremity surgeries, lower extremity surgeries, pain management and other indications segments. In terms of value, the lower extremity surgeries segment is expected to register higher CAGR as compared to other segments by the end of forecast period. Upper and lower extremity surgeries segments collectively accounted for 57.3% revenue share of the overall market in 2015 and is expected to account for 59.5% revenue share by 2026.

Analysis, by End User

On the basis of end user, the continuous peripheral nerve block catheter market is segmented into hospitals and ambulatory surgical centres. In terms of value, the hospitals segment is expected to register higher CAGR as compared to ASCs segment by the end of forecast period. Revenue growth of the hospitals segment is majorly driven by increasing adoption of continuous peripheral nerve block catheter, considering the fact that joint replacement procedure is mainly performed in hospitals.  Hospitals segment accounted for 62.0% revenue share of the overall market in 2015 and is expected to account for 64.8% revenue share by 2026.

Competitive Landscape

Key market players covered in this report are B. Braun Melsungen AG, Teleflex Incorporated, Halyard Health, Inc., Ambu A/S, Epimed International Inc. and Pajunk GmbH. Major players in the continuous peripheral nerve block catheter market focus on enhancing their global and regional presence through introduction of novel products and strategic operational expansion. B. Braun Melsungen AG was the market leader in the global continuous peripheral nerve block catheter market in 2015, owing to its broad product portfolio.

Leave a Reply